NCT03258294View on ClinicalTrials.gov

Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease

PHASE4UnknownINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

January 13, 2016

Primary Completion Date

December 30, 2018

Study Completion Date

December 30, 2018

Conditions
Parkinson's Disease
Interventions
DRUG

Melatonin(Circadin®)

DRUG

Placebo Oral Tablet

Sponsors
All Listed Sponsors
collaborator

Kuhnil Pharmaceutical Co., Ltd.

INDUSTRY

lead

KIMJisun

OTHER